18F-florbetaben PET imaging offers valuable prognostic information in AL-CA. Values of late (50’-60’) Total amyloid burden (i.e. mean standardized uptake value x molecular volume) measured in the LV and RV are strong predictors of all-cause mortality. @GiuseppeVerg
🎓FISIOPATOLOGIA CLINICA E MENAGEMENT DELLO SCOMPENSO CARDIACO - III edizione
🏛Direzione didattica a cura di: Prof. @MicheleEmdin - Dr. Giuseppe Vergaro @SantAnnaPisa
📱visita: https://t.co/QmlarM6JSB
‼️Termine presentazione domanda: 24 Gennaio 2023
Delayed CT/PET [18F]-florbetaben heart uptake represents an accurate noninvasive tool for the diagnosis of cardiac AL amyloidosis, discriminating it from either ATTR or mimicking conditions. Genovesi D, Vergaro G, Giorgetti A.. Emdin M https://t.co/8omTxRM71S
#ACC20/#WCCardio | We asked @GiuseppeVerg a comment about the work by @RanLeeMD et al, [@UMich] which tested the implementation of an inpatient sacubitril-valsartan protocol, combined with increased awareness and an EMR order set tool.
Heart failure breaking news!! May 11 & 12 two days among friends and colleagues in Arezzo, Italy. Our daily duty revised: how novel diagnostic, prognostic and therapeutic tools may help our everyday patient centered effort.. Thanks to all comers!